Intestinal Failure: Clinical Trials

6 trials for Intestinal Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 recruiting, 1 unknown. 6 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 2, Terminated 2, Recruiting 1, Unknown 1
Phase 11Terminated 1
Phase 31Recruiting 1

Follow Intestinal Failure: new trials by email Literature Review of Intestinal Failure trials Research Report on Intestinal Failure

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral Support
Choline Chloride for Injection, Placebo - Choline Deficiency, Liver Injury
Phase 2 / Phase 3RecruitingProtara Therapeutics1292025-12-102026-08-24
8.4% Sodium Bicarbonate Locks in Intestinal Failure
Sodium bicarb lock - Intestinal Failure, CRBSI - Catheter Related Bloodstream Infection
Phase 2CompletedRiad Rahhal62022-12-012026-05-28
Functional Sucrase Deficiency in Short Bowel Syndrome Patients With Intestinal Failure
Sucrase, Placebo - Short Gut Syndrome
Phase 2TerminatedUniversity of Miami32022-01-312025-10-01
Metabolic Balance Study of Apraglutide in Patients With Short Bowel Syndrome, Intestinal Failure (SBS-IF) and Colon-in-Continuity (CIC)
Apraglutide - Short Bowel Syndrome
Phase 2CompletedVectivBio AG102021-06-142025-06-18
Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure
Glucagon-Like Peptide 2, Glucagon like peptide-2 - Intestinal Failure, Short Bowel Syndrome
Phase 1 / Phase 2TerminatedAlberta Children's Hospital132012-01-012014-12-23
Can SMOFlipidĀ®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?
Intralipid 20%, SMOFlipid 20% - Short Bowel Syndrome, Intestinal Failure
Phase 2UnknownThe Hospital for Sick Children242009-01-012011-11-03

Narrower conditions

Short Bowel Syndrome (4)  ·  Hyperphagia (2)  ·  Choline Deficiency (1)  ·  Enterocolitis, Necrotizing (1)  ·  Gastroschisis (1)  ·  Infant Nutrition Disorders (1)  ·  Intestinal Atresia (1)  ·  Liver Failure (1)  ·  Malnutrition (1)

Broader conditions

Digestive System Diseases (6)  ·  Gastrointestinal Diseases (6)  ·  Intestinal Diseases (6)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Malabsorption Syndromes (4)  ·  Pathologic Processes (4)  ·  Postoperative Complications (4)  ·  Nutrition Disorders (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Signs and Symptoms (2)  ·  Signs and Symptoms, Digestive (2)  ·  Avitaminosis (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Deficiency Diseases (1)

Interventions

Choline (1)  ·  Glucagon-Like Peptide 2 (1)  ·  Injections (1)  ·  Sucrase (1)  ·  apraglutide (1)

Sponsors

Alberta Children's Hospital (1)  ·  Protara Therapeutics (1)  ·  Riad Rahhal (1)  ·  The Hospital for Sick Children (1)  ·  University of Miami (1)  ·  VectivBio AG (1)

Countries

United States (3)  ·  Belgium (2)  ·  Canada (2)  ·  France (2)  ·  Denmark (1)  ·  Germany (1)  ·  Poland (1)

Top investigators

Amanda Fifi, MD (1)  ·  David Sigalet, MD PhD (1)  ·  Paul Wales (1)  ·  Tomasz Masior (1)

Results publications

PMID 26838529, PMID 39461299, PMID 41903849